-
AI, Machine Learning & Computational Biology2 months agoData Integrity as the Foundation for AI
In this sponsored podcast, LabVantage’s Gary Stimson digs into what it takes to build a data foundation for trustworthy AI. The post Data Integrity as the...
-
Manufacturing, Supply Chain & Infrastructure2 months agoSmarter Cell Culture Starts with Better Media
Advances in media optimization, cell engineering, and AI are reshaping intensified bioprocessing for higher productivity, better quality, and greater manufacturing efficiency. The post Smarter Cell Culture...
-
Manufacturing, Supply Chain & Infrastructure2 months agoTop 10 Contract Development and Manufacturing Organizations 2026
A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their services. The post Top 10 Contract...
-
Manufacturing, Supply Chain & Infrastructure2 months ago10 CDMO Up & Comers 2026
As one notable company exits the field, growing CDMOs open facilities and secure major contracts. The companies are listed here for making headlines with facility openings,...
-
Manufacturing, Supply Chain & Infrastructure2 months agoThe Multi-Attribute Method (MAM) as a Biologics Lifecycle Backbone
A more coherent approach: a peptide-mapping LC-HRMS (liquid chromatography-high resolution mass spectrometry) workflow that can identify and monitor multiple product quality attributes, including selected critical quality...
-
Synthetic Biology, Genomics & Advanced Therapeutics2 months agoADCs, mAbs, CAR Ts: One Bioluminescent Platform Measures Them All
The HiBiT Target Cell Killing (TCK) platform, with off-the-shelf, mix-and-match components, measures four killing mechanisms for broad immunotherapy modality assessment. The post ADCs, mAbs, CAR Ts:...
-
Synthetic Biology, Genomics & Advanced Therapeutics2 months agoThe Analytical Blueprint for Cell & Gene Therapy Success
This eBook brings together expert perspectives on several of the most pressing analytical topics facing today’s cell and gene therapy developers. The post The Analytical Blueprint...
Widespread atropine use fails to sway FDA advisors on Sydnexis data
At least 11 PDUFAs on FDA’s November docket
FDA Grants Accelerated Approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for Recurrent Respiratory Papillomatosis
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
